Tweet
CANCER RATE DOWN IN ARMENIA COMPARED TO DEVELOPED STATES - DOCTOR
16:17 * 04.02.15
The cancer statistics in Armenia is considerably lower today compared
to the world's developed countries, Armenia's chief oncologist said
today, noting that their comparative dynamics reveals 200 cases less
per 100,000 population.
"Though we can summarize the 2014 records only in March, they can
be said to have remained almost the same. The registered [patients'
statistics] in Armenia reveals 240 cases per a 100,000 residents. It
is a good record if we compare it with those in developed countries.
Their statistics is 450 [cases per 100,000 population]," Head of the
National Center of Oncology Hayrapet Galstyan told reporters.
According to him the disease statistics is almost the same among
males and females.
Asked whether the existing records are real given the high incidence of
cancer, Galstyan said theoir data procession and submission procedures
involve only the registered patients.
"And the registration is on a quite high level today, as that covers
not only the patients admitted to hospital but also those who died
at home. Additionally, we receive data from district polyclinics
and regions, as well as based upon the death certificates issued by
registry offices," said the oncologist.
He said the most widespread form of the disease among the male
population is lung cancer (65.1 per 100,00 population), with
females more frequently developing breast cancer (67.7 cases/100,000
population).
Galstyan said their institution's life expectancy statistics is much
higher compared to that of other medical centers.
As for the general life expectancy in Armenia, the doctor said he
sees that the country considerably falls behind developed states
(i.e. - cancer patients die more frequently in Armenia).
Galstyan explained the trend by the lower degree of patients' care
of health issues. "We have very many cases detected at late stages -
third or fourth - among patients with primary diagnosis. They account
for 43% of the patients, as opposed to the 23% [in different other
countries]," Galstyan said, adding that the statistics very often
varies from country to country.
http://www.tert.am/en/news/2015/02/04/hayrapet-galstyan/1579376
16:17 * 04.02.15
The cancer statistics in Armenia is considerably lower today compared
to the world's developed countries, Armenia's chief oncologist said
today, noting that their comparative dynamics reveals 200 cases less
per 100,000 population.
"Though we can summarize the 2014 records only in March, they can
be said to have remained almost the same. The registered [patients'
statistics] in Armenia reveals 240 cases per a 100,000 residents. It
is a good record if we compare it with those in developed countries.
Their statistics is 450 [cases per 100,000 population]," Head of the
National Center of Oncology Hayrapet Galstyan told reporters.
According to him the disease statistics is almost the same among
males and females.
Asked whether the existing records are real given the high incidence of
cancer, Galstyan said theoir data procession and submission procedures
involve only the registered patients.
"And the registration is on a quite high level today, as that covers
not only the patients admitted to hospital but also those who died
at home. Additionally, we receive data from district polyclinics
and regions, as well as based upon the death certificates issued by
registry offices," said the oncologist.
He said the most widespread form of the disease among the male
population is lung cancer (65.1 per 100,00 population), with
females more frequently developing breast cancer (67.7 cases/100,000
population).
Galstyan said their institution's life expectancy statistics is much
higher compared to that of other medical centers.
As for the general life expectancy in Armenia, the doctor said he
sees that the country considerably falls behind developed states
(i.e. - cancer patients die more frequently in Armenia).
Galstyan explained the trend by the lower degree of patients' care
of health issues. "We have very many cases detected at late stages -
third or fourth - among patients with primary diagnosis. They account
for 43% of the patients, as opposed to the 23% [in different other
countries]," Galstyan said, adding that the statistics very often
varies from country to country.
http://www.tert.am/en/news/2015/02/04/hayrapet-galstyan/1579376